PRQR
ProQR Therapeutics N.V.
NASDAQ · Healthcare · Biotechnology · NL
$2.07
−0.96%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 17.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.16x
- Price / sales
- 13.53x
- Price / cash flow
- -5.11x
Enterprise value
- Enterprise value
- $171.4M
- EV / sales
- 7.94x
- EV / EBITDA
- -3.91x
- EV / EBIT
- -3.41x
- Market cap
- $292.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026